ArticlePoultry science2026
A national study confirms a low occurrence of antimicrobial resistance amongst Escherichia coli isolates from the caecae of Australian meat chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In meat chickens, Escherichia coli has been widely used as an indicator of overall carriage of antimicrobial resistance (AMR), with low levels of AMR found in Australia's 2016 national survey. This follow-up survey applied a high-throughput robotic antimicrobial-susceptibility platform to increase the probability of detecting rare but clinically significant forms of resistance, obtain higher-resolution prevalence estimates and assess possible temporal changes in amounts and types of resistance. Pooled caecal samples were collected at slaughter from 20 processing plants covering > 90% of Australian national chicken meat production. E. coli colonies were tested by broth micro-dilution against 14 antimicrobials and whole-genome sequencing was performed on all isolates that were clinically resistant to ciprofloxacin. Among 2,950 E. coli isolates, 56.8% were wild-type to every drug and all were susceptible to colistin and amikacin. Non-wild-type (NWT) rates were highest for tetracycline (23.3%, 95% CI 21.7-24.8%) and ampicillin (11.7%, 95% CI 10.5-12.9%); NWT prevalence for ciprofloxacin was 3.3% (2.6-4.0%, 95% CI 2.6-4.0%) but only 1.1% were resistant at the clinical breakpoint. Multi-class resistance was rare (2.9%). The genomes of 32 ciprofloxacin-resistant isolates were sequenced: 25 (78%) carried canonical gyrA/parC mutations and mainly clustered in two lineages, ST354 (n = 16) and ST752 (n = 9). When compared to contemporary European Union surveillance data, E. coli colonizing Australian meat-chickens continue to exhibit relatively low levels of resistance to first line and critically important antimicrobials. The stable but detectable presence of fluoroquinolone-resistant ST354 and ST752 underscores the need for regular large-scale, genomics-enabled surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.